SG10202001578RA - Rodents having a humanized tmprss gene - Google Patents

Rodents having a humanized tmprss gene

Info

Publication number
SG10202001578RA
SG10202001578RA SG10202001578RA SG10202001578RA SG10202001578RA SG 10202001578R A SG10202001578R A SG 10202001578RA SG 10202001578R A SG10202001578R A SG 10202001578RA SG 10202001578R A SG10202001578R A SG 10202001578RA SG 10202001578R A SG10202001578R A SG 10202001578RA
Authority
SG
Singapore
Prior art keywords
rodents
tmprss gene
humanized tmprss
humanized
gene
Prior art date
Application number
SG10202001578RA
Inventor
Ngambo Lisa Purcell
Alexander O Mujica
Yajun Tang
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of SG10202001578RA publication Critical patent/SG10202001578RA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0337—Animal models for infectious diseases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10332—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Environmental Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG10202001578RA 2016-02-29 2017-02-27 Rodents having a humanized tmprss gene SG10202001578RA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662301023P 2016-02-29 2016-02-29

Publications (1)

Publication Number Publication Date
SG10202001578RA true SG10202001578RA (en) 2020-04-29

Family

ID=58264641

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201807038UA SG11201807038UA (en) 2016-02-29 2017-02-27 Rodents having a humanized tmprss gene
SG10202001578RA SG10202001578RA (en) 2016-02-29 2017-02-27 Rodents having a humanized tmprss gene

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11201807038UA SG11201807038UA (en) 2016-02-29 2017-02-27 Rodents having a humanized tmprss gene

Country Status (14)

Country Link
US (5) US10070632B2 (en)
EP (2) EP3422845B1 (en)
JP (1) JP6980674B2 (en)
KR (2) KR102493894B1 (en)
CN (1) CN109068621B (en)
AU (1) AU2017228293B2 (en)
CA (1) CA3014645C (en)
DK (1) DK3422845T3 (en)
ES (1) ES2886958T3 (en)
IL (1) IL261139B (en)
PT (1) PT3422845T (en)
RU (1) RU2749715C2 (en)
SG (2) SG11201807038UA (en)
WO (1) WO2017151453A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102493894B1 (en) * 2016-02-29 2023-01-31 리제너론 파마슈티칼스 인코포레이티드 Rodents with a humanized TMPRSS gene
EP4276185A3 (en) * 2017-09-29 2024-02-21 Regeneron Pharmaceuticals, Inc. Rodents comprising a humanized ttr locus and methods of use
MA46731B1 (en) 2018-01-26 2021-06-30 Regeneron Pharma Anti-tmprss2 antibodies and antigen binding fragments
CN116200426A (en) 2018-07-16 2023-06-02 瑞泽恩制药公司 Non-human animal model of DITRA disease and uses thereof
MX2021008291A (en) 2019-01-17 2021-08-05 Regeneron Pharma A rodent model of mood disorders.
AU2021219671A1 (en) 2020-02-10 2022-07-14 Regeneron Pharmaceuticals, Inc. Anti-Tmprss2 Antibodies and Antigen-Binding Fragments
CN115161326A (en) * 2021-06-21 2022-10-11 百奥赛图(北京)医药科技股份有限公司 SOST gene humanized non-human animal and construction method and application thereof
WO2023122506A1 (en) * 2021-12-20 2023-06-29 Regeneron Pharmaceuticals, Inc. Non-human animals comprising humanized ace2 and tmprss loci

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002065266A (en) * 2000-08-28 2002-03-05 Teijin Ltd Airway-specific trypsin-like enzyme and method for utilizing the same
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US7479579B2 (en) * 2001-12-20 2009-01-20 The Regents Of The University Of California Triple transgenic mouse model of Alzheimer's disease
US20050026255A1 (en) * 2002-06-25 2005-02-03 Morser John Michael Corin, a serine protease
EP1558731A4 (en) * 2002-10-04 2007-01-10 Schering Ag Modified hepsin molecules having a substitute activation sequence and uses thereof
RU2006100035A (en) * 2003-06-11 2006-08-27 Шеринг Акциенгезельшафт (De) NEW MODIFIED CORIN MOLECULES HAVING SUBSTITUTED ACTIVATING SEQUENCES, AND THEIR APPLICATION
US7491865B2 (en) * 2004-08-19 2009-02-17 Fred Hutchinson Cancer Research Center Mouse models of prostate cancer development and metastasis through expression of a hepsin transgene
ES2667169T3 (en) 2004-10-19 2018-05-09 Regeneron Pharmaceuticals, Inc. Method to generate a homozygous non-human animal for genetic modification
CA2651043A1 (en) * 2006-05-23 2007-12-06 David C. Tully Compounds and compositions as channel activating protease inhibitors
GB0821624D0 (en) * 2008-11-26 2008-12-31 Eisai London Res Lab Ltd Assay
JP5851842B2 (en) * 2009-01-12 2016-02-03 サイトムエックス セラピューティクス, インク.CytomX Therapeutics, Inc. Modified antibody composition and methods of making and using the same
RU2425880C2 (en) * 2009-07-30 2011-08-10 Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН Method of producing transgene mice
ES2908587T3 (en) 2009-10-06 2022-05-03 Regeneron Pharma Genetically modified mice and graft
DK3375284T3 (en) * 2011-02-15 2023-06-12 Univ Yale Humanized M-CSF mice and uses thereof
SI2770821T1 (en) 2011-10-28 2018-01-31 Regeneron Pharmaceuticals, Inc. Genetically modified major histocompatibility complex mice
HUE048511T2 (en) 2011-10-28 2020-07-28 Regeneron Pharma Genetically modified mice expressing chimeric major histocompatibility complex (mhc) ii molecules
SG10201600965YA (en) 2011-10-28 2016-03-30 Regeneron Pharma Humanized il-6 and il-6 receptor
BR112014025339A8 (en) * 2012-04-16 2018-01-16 Regeneron Pharma method for treating or preventing or reducing influenza virus infection and pharmaceutical composition therefor.
US8962913B2 (en) 2012-06-18 2015-02-24 Regeneron Pharmaceuticals, Inc. Humanized IL-7 rodents
PE20150643A1 (en) * 2012-06-22 2015-05-29 Cytomx Therapeutics Inc ANTI-JAGGED 1 / JAGGED 2 CROSS-REACTIVE ANTIBODIES ACTIVABLE ANTI-JAGGED ANTIBODIES AND METHODS OF USE OF THEM
EP4193834A1 (en) 2012-09-07 2023-06-14 Yale University Genetically modified non-human animals and methods of use thereof
EP3556206B1 (en) 2012-11-05 2021-06-02 Regeneron Pharmaceuticals, Inc. Genetically modified non-human animals and methods of use thereof
HUE045478T2 (en) 2013-02-20 2019-12-30 Regeneron Pharma Mice expressing humanized t-cell co-receptors
EP2958990B1 (en) 2013-02-20 2019-10-16 Regeneron Pharmaceuticals, Inc. Genetic modification of rats
JP6444321B2 (en) 2013-02-22 2018-12-26 リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． Mice expressing humanized major histocompatibility gene complex
US20150342163A1 (en) 2013-02-22 2015-12-03 Regeneron Pharmaceuticals, Inc. Genetically modified major histocompatibility complex mice
HUE040575T2 (en) 2013-04-16 2019-03-28 Regeneron Pharma Targeted modification of rat genome
CA2913732A1 (en) 2013-06-04 2014-12-11 Cytomx Therapeutics, Inc. Compositions and methods for conjugating activatable antibodies
RS64573B1 (en) 2013-09-23 2023-10-31 Regeneron Pharma Non-human animals having a humanized signal-regulatory protein gene
SI3138397T1 (en) 2013-10-15 2019-04-30 Regeneron Pharmaceuticals, Inc. Humanized il-15 animals
JP6484237B2 (en) 2013-11-19 2019-03-13 リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． Non-human animals having humanized growth-inducing ligand genes
WO2015077071A1 (en) 2013-11-19 2015-05-28 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized b-cell activating factor gene
ES2794942T3 (en) 2014-04-08 2020-11-19 Regeneron Pharma Non-human animals that have humanized Fc-gamma receptors
NO2785538T3 (en) 2014-05-07 2018-08-04
DK3841877T3 (en) 2014-05-19 2023-11-27 Regeneron Pharma Genetically modified mouse expressing human EPO
RU2735958C2 (en) 2014-06-19 2020-11-11 Регенерон Фармасьютикалз, Инк. Animals other than humans having a humanized gene 1 of programmed cell death
RU2020122439A (en) 2014-11-24 2020-09-24 Регенерон Фармасьютикалз, Инк. NON-HUMAN ANIMALS EXPRESSING HUMANIZED CD3 COMPLEX
US20160345549A1 (en) 2014-12-05 2016-12-01 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized cluster of differentiation 47 gene
PT3230320T (en) 2014-12-09 2021-01-08 Regeneron Pharma Non-human animals having a humanized cluster of differentiation 274 gene
HRP20231039T1 (en) 2015-04-06 2023-12-22 Regeneron Pharmaceuticals, Inc. Humanized t cell mediated immune responses in non-human animals
KR102454546B1 (en) 2015-11-20 2022-10-14 리제너론 파마슈티칼스 인코포레이티드 Non-human animals with humanized lymphocyte activation gene 3
KR102493894B1 (en) 2016-02-29 2023-01-31 리제너론 파마슈티칼스 인코포레이티드 Rodents with a humanized TMPRSS gene
KR101693243B1 (en) * 2016-06-15 2017-01-05 재단법인 한국파스퇴르연구소 Novel human gene crucial for the replication of influenza virus and use thereof

Also Published As

Publication number Publication date
EP3895529A1 (en) 2021-10-20
US20240147971A1 (en) 2024-05-09
RU2018131152A3 (en) 2020-07-13
ES2886958T3 (en) 2021-12-21
RU2018131152A (en) 2020-04-01
AU2017228293A1 (en) 2018-08-23
US20170290308A1 (en) 2017-10-12
IL261139A (en) 2018-10-31
DK3422845T3 (en) 2021-08-30
WO2017151453A1 (en) 2017-09-08
CN109068621B (en) 2021-07-20
JP6980674B2 (en) 2021-12-15
SG11201807038UA (en) 2018-09-27
IL261139B (en) 2022-04-01
US20180332831A1 (en) 2018-11-22
CA3014645C (en) 2022-10-25
PT3422845T (en) 2021-08-26
US10863729B2 (en) 2020-12-15
KR20180117122A (en) 2018-10-26
US20170245482A1 (en) 2017-08-31
KR102493894B1 (en) 2023-01-31
US10070631B2 (en) 2018-09-11
EP3422845A1 (en) 2019-01-09
US11910787B2 (en) 2024-02-27
CA3014645A1 (en) 2017-09-08
US20210068377A1 (en) 2021-03-11
JP2019511918A (en) 2019-05-09
US10070632B2 (en) 2018-09-11
EP3422845B1 (en) 2021-06-02
RU2749715C2 (en) 2021-06-16
AU2017228293B2 (en) 2023-05-25
KR20230021759A (en) 2023-02-14
CN109068621A (en) 2018-12-21

Similar Documents

Publication Publication Date Title
IL261139B (en) Rodents having a humanized tmprss gene
EP3414381A4 (en) A leash
IL248871B (en) Deflecting bend
IL271561A (en) Non-human animals comprising a humanized asgr1 locus
GB201709183D0 (en) A wingsail
GB201504306D0 (en) A slide assembly
GB201805865D0 (en) Genes
GB2557959B (en) A reel
GB201813223D0 (en) A atroller
GB201413261D0 (en) A tandem reel assembly
GB2553815B (en) A fixing
GB2547218B (en) A shotgun
AU2016904672A0 (en) A thermostat
GB201618056D0 (en) A tray
AU201711826S (en) a playsuit
AU201615510S (en) A Playsuit
GB201621946D0 (en) Herbicidal compounds
GB201621947D0 (en) Herbicidal compounds
GB201621758D0 (en) Herbicidal compounds
GB201621760D0 (en) Herbicidal compounds
GB201621763D0 (en) Herbicidal Compounds
GB201621754D0 (en) Herbicidal Compounds
GB201621755D0 (en) Herbicidal Compounds
GB201621756D0 (en) Herbicidal compounds
GB201621757D0 (en) Herbicidal compounds